Replies to post #36457 on NanoViricides Inc (NNVC)

[Ubertino]

Oh!

Perhaps NanoViricides EKC-Cide treatment would be better.

Someone should try it!!

Ref:
Phase II trials have begun for a novel compound called NVC-422 (Aganocide, NovaBay/Alcon) for the treatment of viral conjunctivitis. The drug is composed of proprietary analogs to the N-chlorinated molecules used by white blood cells to destroy viruses and bacteria.23 Additionally, a drug known as EkcCide (Nanoviricides) is currently in preclinical development and has shown efficacy in eliminating EKC symptoms in rabbits infected with adenovirus 5. EkcCide is part of a new class of drugs specifically designed to attack enveloped virus particles and dismantle them.24

23. Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis. NovaBay website. http://www.novabaypharma.com/investors/release/july_05_2009. Accessed January 22, 2010.
24. Nanoviricides, Inc. http://www.nanoviricides.com. Accessed January 22, 2010.

http://www.revophth.com/index.asp?page=1_14603.htm

[Ubertino]

Perhaps Alcon will be looking for a better treatment, then?

I note our present big pharma EKC deal is going to be finished shortly!